Neomorph is a biotech company developing innovative medicines against 'undruggable targets' in human health. Their team of experts in protein degradation and molecular glues are committed to advancing the science and technology of molecular glue drug discovery. They prioritize a patient-first, science-driven approach and maintain a supportive and collaborative work environment. Neomorph is based in San Diego and collaborates with the Center for Protein Degradation at the Dana Farber Cancer Institute.